NKTR

Nektar Therapeutics

Price:

1.32

USD

Volume:

785,340.00

United States | Pharmaceuticals

-464.31 %

Upside

As of 2024-10-07, the Fair Value of Nektar Therapeutics (NKTR) is -4.81 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.32 USD, the upside of Nektar Therapeutics is -464.31%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.32 USD

Stock Price

-4.81 USD

Fair Price

Peter Lynch's formula is:

NKTR Fair Value

= Earnings Growth Rate x TTM EPS
NKTR Fair Value

= 5.00 x -0.96
NKTR Fair Value

= -4.81
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -440.70 | -444.40 | -523.80 | -368.20 | -276.06 | -410.63 |

YoY growth | -164.69% | -0.84% | -17.87% | 29.71% | 25.03% | -25.73% |

Market Cap (mil) | 242.99 |

P/E | |

Forward P/E |

EPS | -0.96 |

Avg earnings growth rate | -25.73% |

TTM earnings | -177.04 |